Effect of metabolites of chlorpromazine on plasma prolactin levels in male rats.

[1]  A. Carlsson,et al.  EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN. , 2009, Acta pharmacologica et toxicologica.

[2]  C. Marsden,et al.  Metoclopramide and dopamine receptor blockade , 1976, Neuropharmacology.

[3]  S H Snyder,et al.  Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs , 1976, Science.

[4]  H. Meltzer,et al.  Clozapine increases rat serum prolactin levels. , 1975, Life sciences.

[5]  L. Iversen.  Dopamine receptors in the brain. , 1975, Science.

[6]  S. Snyder,et al.  Phenothiazine drugs: structure-activity relationships explained by a conformation that mimics dopamine. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[7]  A. Mackay,et al.  The relationship of plasma chlorpromazine to its 7-hydroxy and sulphoxide metabolites in a large population of chronic schizophrenics. , 1974, British journal of clinical pharmacology.

[8]  D. Lawson,et al.  The influence of surgery, time of day, blood volume reduction and anaesthetics on plasma prolactin in ovariectomized rats. , 1974, The Journal of endocrinology.

[9]  S H Snyder,et al.  Drugs, neurotransmitters, and schizophrenia. , 1974, Science.

[10]  P. Greengard,et al.  Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor". , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[11]  T. Sourkes,et al.  Effect of various chlorpromazine metabolites on amphetamine-induced stereotyped behaviour in the rat. , 1972, European journal of pharmacology.

[12]  S. Snyder,et al.  Chlorpromazine and dopamine: conformational similarities that correlate with the antischizophrenic activity of phenothiazine drugs. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. R. Harris,et al.  Appearance of monohydroxylated chlorpromazine metabolites in the central nervous system. , 1971, Life sciences. Pt. 1: Physiology and pharmacology.

[14]  M. Ben-david,et al.  Structure-activity-relationship of mammotropic phenothiazine derivaties. , 1968, Archives internationales de pharmacodynamie et de therapie.

[15]  A. A. Manian,et al.  A comparative pharmacological study of a series of monohydroxylated and methoxylated chlorpromazine derivatives. , 1965, Life sciences.

[16]  E. Hearst,et al.  PHARMACOLOGICAL ACTIVITY OF 1-, 2-, AND 3-HYDROXYPROMAZINE AND 7-METHOXYCHLORPROMAZINE. , 1964, International journal of neuropharmacology.

[17]  G. C. Palmer,et al.  Actions of phenothiazine analogues on dopamine-sensitive adenylate cyclase in neuronal and glial-enriched fractions from rat brain. , 1976, Biochemical pharmacology.

[18]  G. Sedvall,et al.  Actions of dopaminergic antagonists in the striatum. , 1975, Advances in neurology.

[19]  T. Grover,et al.  Red blood cell drug binding as a possible mechanism for tranquilization. , 1974, Advances in biochemical psychopharmacology.

[20]  J. Clemens,et al.  Hypothalamic control of prolactin secretion. , 1972, Vitamins and hormones.

[21]  M. Ben-david,et al.  Acute changes in blood and pituitary prolactin after a single injection of perphenazine. , 1970, Neuroendocrinology.